A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
for Chronic Lymphocytic Leukemia
21 locations incl. Chandler
Sponsor: Loxo Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06588478·Phase 2·Recruiting·Listed Sep 2024